Abstract In Coryne bacte rium g lu t amic um , the phosphoenolpyruvate-dependent sugar phosphotransferase system (PTS) has long been the only known glucose uptake system, but we recently found suppressor mutants emerging from a PTS-negative strain of C. glutamicum ATCC 31833 on glucose agar plates, and identified two alternative potential glucose uptake systems, the myo-inositol transporters encoded by iolT1 and iolT2.
Introduction
Corynebacterium glutamicum is an industrially important microorganism that is widely used for the production of various amino acids (Kinoshita and Nakayama 1978; Eggeling and Bott 2005; Ikeda and Takeno 2013) . This microorganism uses the phosphoenolpyruvate-dependent sugar phosphotransferase system (PTS) to take up and phosphorylate glucose, as well as fructose and sucrose (Mori and Shiio 1987; Parche et al. 2001) . The representative C. glutamicum wildtype strain ATCC 13032 has four sets of PTSs, one each that is specific for glucose, fructose, sucrose, and an unknown substrate (Parche et al. 2001; Moon et al. 2007 ). The glucose-PTS consists of the glucose-specific EIIABC component (EII Glc ) encoded by ptsG (Cgl1360, NCgl1305) and the two general components EI and HPr encoded by ptsI (Cgl1933, NCgl1858) and ptsH (Cgl1937, NCgl1862), respectively. Disruption of any of the genes in strain ATCC 13032 results in a phenotype exhibiting little growth on glucose (Parche et al. 2001) . Exceptionally, another wildtype strain C. glutamicum R can consume glucose not only via the glucose-PTS but also via the β-glucoside-PTS because C. glutamicum R, unlike C. glutamicum ATCC 13032, has two sets of β-glucoside-PTSs that are redundantly responsible for the uptake of the β-glucosides, such as salicin and arbutin, and also glucose (Kotrba et al. 2003; Tanaka et al. 2009 Tanaka et al. , 2011 .
Although glucose uptake and subsequent phosphorylation in wild-type C. glutamicum depends on the PTS, glucokinase activity catalyzing ATP-dependent phosphorylation of glucose into glucose-6-phosphate has been reported for this organism. The enzyme GLK, which is encoded by glk (Cgl2185, NCgl2105), has been shown to be involved in the metabolism of the disaccharide maltose, which is hydrolyzed to free glucose inside the cell (Park et al. 2000 ). An additional glucokinase encoded by ppgK (Cgl1910, NCgl1835) has been reported (Lindner et al. 2010) . The enzyme PPGK has been shown to strongly prefer polyphosphate over ATP as a phosphoryl donor and is therefore assumed to be especially important under growth conditions depending on high intracellular polyphosphate concentrations. Recently, we identified a third enzyme that can be involved in the phosphorylation of intracellular glucose (Ikeda 2012 ). The enzyme CGL2647, which is encoded by the Cgl2647 (NCgl2558) gene, shows approximately 29 and 25 % sequence identity with GLK and PPGK, respectively, while GLK and PPGK share 28 % identity with each other.
Our laboratories aim at a better understanding of the entire cellular system of C. glutamicum and also at the discovery of new methods allowing us to fully draw out the potential of this microorganism as a workhorse for the production of useful compounds from renewable feedstocks (Ikeda et al. 2013a; Takeno et al. 2010 Takeno et al. , 2013 . Recently, we happened to find that colonies emerged on glucose agar plates from WTΔptsH, a ptsH-disrupted strain of the C. glutamicum wild-type strain WT-96 (ATCC 31833) , at a frequency of 10 −5 (Ikeda et al. 2011) . Since the suppressor strain SPH2 (Fig. 1) , unlike the wild-type strain, exhibited a phenotype of resistance to 2-deoxyglucose, which is known to be a toxic substrate for the glucose-PTS of this organism (Mori and Shiio 1987) , we predicted that the suppressor strain would utilize glucose via a different system involving a particular permease and the native glucokinases. Our analysis following these observations eventually led to the finding that two myo-inositol transporters encoded by iolT1 (Cgl0181, NCgl0178) and iolT2 (Cgl3058, NCgl2953) mediate glucose uptake in this organism and that glucose phosphorylation depends on glucokinase activity (Ikeda 2012; Ikeda et al. 2011) . We also showed that inactivation of iolR, a putative transcriptional regulator gene, enables strain WTΔptsH to grow on glucose through the derepression of iolT1, as was the case with the suppressor strain SPH2. Therefore, strain SPH2 loses the ability to grow on glucose when iolT1 is disrupted (Fig. 1 ). Based on these results, we established a strategy for engineering C. glutamicum to express the iolT1-specified glucose uptake bypass instead of the original PTS, and demonstrated the usefulness of this strategy using lysine fermentation as a model (Ikeda 2012; Ikeda et al. 2011) . In keeping with our results, a German group has independently identified two myo-inositol transporters as alternatives to the PTS in this organism and shown the advantage of expressing the non-PTS route(s) in lysine production (Lindner et al. 2011a, b) . During the course of our studies, we found another suppressor strain that still grew on glucose even after the iolT1 and iolT2 genes were both disrupted under a PTS-negative background. The suppressor strain SPH1 (Fig. 1) , like strain SPH2, was identified from among the colonies that emerged from strain WTΔptsH on glucose agar plates; it exhibited a phenotype of resistance to 2-deoxyglucose. This finding led us to predict that a different glucose uptake bypass was operating in strain SPH1. Here, we describe the identification of a third bypass route, which is expressed in strain SPH1, as well as the suppressor mutation, which renders a PTS-negative strain capable of growing on glucose. Finally, an overall picture of potential glucose uptake bypasses in C. glutamicum is summarized.
Wild strain WT-96 (ATCC 31833) [ 
Materials and methods

Bacterial strains
The wild-type strain of C. glutamicum used in this study is strain WT-96, a single-colony derivative of C. glutamicum ATCC 31833. Strains WTΔptsH, WTΔptsI, and WTΔptsHI are WT-96-derived PTS-negative mutants, which have deletions in ptsH, ptsI, and both of them, respectively. Strain SPH2 is one of the suppressor mutants that arose spontaneously from the PTS-negative strain WTΔptsH on an MM agar plate with glucose (Ikeda et al. 2011) . This strain carries a suppressor mutation leading to inactivation of iolR, a putative transcriptional regulator gene. Strain SPH1 used in this study is another suppressor mutant that arose from the PTS-negative strain. This suppressor strain, unlike strain SPH2, was able to grow on glucose even after the iolT1 and iolT2 genes were both deleted. Strain SPHΔggg is a SPH1-derived mutant, which has triple deletions of the three glucokinase genes glk, ppgK, and Cgl2647. Escherichia coli DH5α was used as a host for DNA manipulation.
Plasmids
Plasmid pCS299P (Mitsuhashi et al. 2004 ), a C. glutamicum-E. coli shuttle vector, was used to construct a genomic library and also to clone the PCR products. Plasmid pESB30 (Mitsuhashi et al. 2004) , which is nonreplicative in C. glutamicum, is a vector for gene replacement in C. glutamicum. Plasmids pCbglF, pCglk, pCppgK, and pC2647 were used to constitutively express the bglF, glk (Cgl2185, NCgl2105), ppgK (Cgl1910, NCgl1835), and Cgl2647 (NCgl2558) genes, respectively, under the promoter of the endogenous gapA gene. For the construction of pCbglF, the coding region of bglF was PCR-amplified using primers bglFgapFusF and bglFdown100RBglII with WT-96 genomic DNA as a template. On the other hand, the genomic region from −1 to −558 bp upstream of the gapA gene, which comprises its promoter, was amplified using primers PgapAKpBgF and bglFgapFusR. These two fragments were fused by PCR with the primers PgapAKpBgF and bglFdown100RBglII. The resulting 2.6-kb fragment was digested with BglII and then ligated to BamHI-digested pCS299P to yield pCbglF. Similarly, for the construction of pCglk, the coding region of glk was PCR-amplified using primers Cgl2185gapFusF and Cgl2185down200RBglII with WT-96 genomic DNA as a template. The genomic region upstream of the gapA gene was amplified using primers PgapAKpBgF and Cgl2185gapFusR. These two fragments were fused by PCR with the primers PgapAKpBgF and Cgl2185down200RBglII. The resulting 1.8-kb fragment was digested with BglII and then ligated to BamHI-digested pCS299P to yield pCglk. For the construction of pCppgK, the coding region of ppgK was PCR amplified using primers Cgl1910gapFusF and Cgl1910down500RKpnI with WT-96 genomic DNA as a template. The genomic region upstream of the gapA gene was amplified using primers PgapAKpBgF and Cgl1910gapFusR. These two fragments were fused by PCR with the primers PgapAKpBgF and Cgl1910down500RKpnI. The resulting 1.8-kb fragment was digested with KpnI and then ligated to KpnI-digested pCS299P to yield pCppgK. For the construction of pC2647, the coding region of Cgl2647 was PCR amplified using primers Cgl2647gapFusF and Cgl2647down200RBglII with WT-96 genomic DNA as a template. The genomic region upstream of the gapA gene was amplified using primers PgapAKpBgF and Cgl2647gapFusR. These two fragments were fused by PCR with the primers PgapAKpBgF and Cgl2647down200RBglII. The resulting 1.7-kb fragment was digested with BglII and then ligated to BamHI-digested pCS299P to yield pC2647. The sequences of the primers used in this study are listed in Table S1 in the supplemental material. Primers used for the construction of plasmids pCBglF, pCBglF134
up (see below), and pCbglFd (see below), and for the qPCR analysis of the bglF gene expression, were designed on the basis of the genomic sequence of C. glutamicum WT-96. The other primers were designed on the basis of the genomic sequence of C. glutamicum ATCC 13032 (BA000036), which is publicly available at http://www.genome.jp/kegg/genes.html (Ikeda and Nakagawa 2003) .
Media and culture conditions
Complete medium BY and minimal medium MM were used for growth of C. glutamicum strains (Takeno et al. 2007 ). MM medium contained 1 % glucose as the sole carbon source. When required, kanamycin was added at a final concentration of 20 mg/L. For growth test in liquid culture, 0.05 mL of the seed culture grown aerobically at 30°C in BY medium for 12 h was inoculated into 5 mL of medium in an L-type test tube and cultivated at 30°C using a Monod shaker at 40 strokes/min.
Recombinant DNA techniques
Standard protocols (Sambrook and Russell 2001) were used for the construction, purification, and analysis of plasmid DNA and for the transformation of E. coli. Extraction of C. glutamicum chromosomal DNA and transformation of C. glutamicum by electroporation were carried out as described previously (Takeno et al. 2007) . PCR was performed using a DNA thermal cycler (GeneAmp PCR System 9700, Applied Biosystems, Carlsbad, CA, USA) using Phusion High-Fidelity DNA Polymerase (New England BioLabs, Ipswich, MA, USA).
Identification of the suppressor mutation in strain SPH1
The suppressor mutation in strain SPH1 was identified via a comparative genome analysis using the strain WT-96 genome as a reference. Whole-genome sequencing of strains SPH1 and WT-96 was performed by Takara Bio Inc (Shiga, Japan) using an Illumina Genome Analyzer IIx (Illumina, San Diego, CA, USA).
Strain construction
For the generation of a strain carrying the specific mutation at 134 bp upstream of the bglF gene of strain WTΔptsH, plasmid pCbglF134 up was constructed as follows. A region containing the mutation, in addition to the intact bglF gene, was PCR amplified using primers bglFup800FBglII and bglFdown100RBglII with strain SPH1 genomic DNA as a template. After verification by DNA sequencing, the 2.8-kb PCR product was digested with BglII and then ligated to pESB30 to yield pCbglF134 up . This plasmid was used to replace the wild-type sequence with the mutated sequence as described previously (Ohnishi et al. 2002) . The presence of the mutation was confirmed by allele-specific PCR and DNA sequencing. The nucleotide sequence of the 2.8-kb DNA fragment from C. glutamicum ATCC 31833 was deposited in DDBJ under accession number LC009376.
For the chromosomal deletion of bglF, ptsI (Cgl1933, NCgl1858), glk, ppgK, and Cgl2647, plasmids pCbglFd, pCptsId, pCglkd, pCppgKd, and pC2647d, which contained internally deleted copies of the corresponding genes, were used to replace the wild-type chromosomal genes with the deleted genes. For the construction of plasmid pCbglFd, the 5′-regions of the bglF gene were amplified by PCR using primers bglFup800FBglII and bglFdelFusR with SPH1 genomic DNA as a template. Similarly, the 3′ region of the gene w as a m p l i f i e d u s i n g p r i m e r s b g l F d e l F u s F a n d bglFdown700RBglII. Fusion PCR was then performed using the purified 5′-and 3′-region fragments as templates and the primers bglFup800FBglII and bglFdown700RBglII. The resulting 1.5-kb fused fragment was digested with BglII and then ligated to BamHI-digested pESB30 to yield pCbglFd. Likewise, for the construction of plasmid pCptsId, the 5′ and 3′ regions of the ptsI gene were amplified using two pairs of primers with WT-96 genomic DNA: the pair comprising ptsIup800F and ptsIFusR and the pair comprising ptsIFusF and ptsIdown800RBamHI, respectively. Two resulting fragments were fused by PCR, digested with BamHI and then ligated to BamHI-digested pESB30 to yield pCptsId. Similarly, for the construction of plasmid pCglkd, the 5′ and 3′ regions of the glk gene were amplified using two pairs of primers with WT-96 genomic DNA: the pair comprising Cgl2185up800FBglII and Cgl2185delFusR and the pair comprising Cgl2185delFusF and Cgl2185down800RBglII, respectively. Two fragments were fused by PCR, digested with BglII, and then ligated to pESB30 to yield pCglkd. Plasmid pCppgKd was constructed as follows. The 5′ and 3′ regions of the ppgK gene were amplified using two pairs of primers with WT-96 genomic DNA: the pair comprising Cgl1910up800FBamHI and Cgl1910delFusR and the pair comprising Cgl1910delFusF and Cgl1910down900RBamHI, respectively. Two resulting fragments were fused by PCR, digested with BamHI, and then ligated into BamHI-digested pESB30 to yield pCppgKd. For the construction of plasmid pC2647d, the 5′ and 3′ regions of the Cgl2647 gene were amplified using two pairs of primers with WT-96 genomic DNA: the pair comprising Cgl2647up600FBglII and Cgl2647delFusR and the pair comprising Cgl2647delFusF and Cgl2647down800RBglII, respectively. Two resulting fragments were fused by PCR, digested with BglII and then ligated to BamHI-digested pESB30 to yield pC2647d. Defined chromosomal deletion of the individual gene was accomplished using each plasmid via two recombination events as described previously (Ohnishi et al. 2002) .
RNA extraction, cDNA synthesis, and qPCR Extraction of total RNAs from C. glutamicum strains and subsequent purification were performed as described previously . Synthesis of cDNA was performed with 300 ng of RNA as described by Kind et al. (2011) . Quantitative PCR (qPCR) analysis was performed by the method described by Katayama et al. (2013) . The gene expression levels were standardized to the constitutive level of 16S rRNA expression and calculated according to the comparative cycle threshold method (Schmittgen and Livak 2008) .
Analysis
Cell growth was monitored by measuring the optical density of the culture broth at 660 nm (OD 660 ) with a Miniphoto 518R spectrophotometer (Taitec, Saitama, Japan).
Results
Identification of the suppressor mutation in strain SPH1
Strain SPH1 is one of the suppressor mutants that arose spontaneously from the PTS-negative strain WTΔptsH on an MM agar plate with glucose (Fig. 1) . Since this strain still grew on glucose even after the iolT1 and iolT2 genes were both disrupted, we assumed that a third glucose uptake bypass was operating in the strain. To identify the bypass route, we first attempted transcriptome analysis using DNA microarrays because the relevant gene(s) was thought to be upregulated in the suppressor strain SPH1. When total RNAs from midexponential phase cultures on glucose were used to study differential transcription profiles between strain SPH1 and its parental wild-type WT-96, a single-colony derivative of C. glutamicum ATCC 31833, we failed to find any candidate genes that were upregulated in strain SPH1 compared to the wild-type levels (data not shown). As it turned out afterwards, the failure was not due to our hypothesis itself but rather to the design of our microarrays (see "Discussion"). We then conducted whole-genome sequencing of strains SPH1 and WT-96 to identify the suppressor mutation carried by strain SPH1. By comparing both genome sequences, we found a specific mutation (designated mutation bglF134 up ), a G-to-T exchange at 134 bp upstream of the bglF gene encoding an EII component of the β-glucoside-PTS (Fig. 2) . Genome sequencing also revealed that the bglF gene was located in the cluster bglFbglA-bglG, which has previously been identified as the β-glucoside utilization system in another wild-type C. glutamicum R (Kotrba et al. 2003; Tanaka et al. 2009 Tanaka et al. , 2011 . Interestingly, a search for C. glutamicum genome databases revealed that the bglF-bglA-bglG DNA region including the upstream mutation site was missing from the corresponding position in the genome of C. glutamicum R and ATCC 13032 (Fig. 2) . Introduction of the bglF134 up mutation into strain WTΔptsH actually allowed the PTSnegative strain to grow on glucose: The growth profile in MM medium with glucose as the sole carbon source was almost the same as that of strain SPH1 (Fig. 3) . These results indicate that the suppressor mutation in strain SPH1 is bglF134 up .
Effects of the bglF134 up mutation on the transcript level of bglF expression Since the bglF134 up mutation is located just near the ribonucleic antiterminator (RAT) sequence to which the bglGencoded antiterminator protein binds in response to the presence of β-glucoside (Kotrba et al. 2003; Tanaka et al. 2009) (Fig. 2) , the mutation was considered to affect the transcript level of the downstream bglF gene. Accordingly, we used reverse transcription (RT)-qPCR to investigate the transcript levels of bglF in the suppressor strain SPH1 and strain WTΔptsH carrying the bglF134 up mutation, using the wildtype strain WT-96 as a control. As shown in Fig. 4 , the two strains that carried the bglF134 up mutation exhibited approximately 11-fold increased transcript levels of bglF compared to the wild type. Considering that the mutation generates a mismatch in the base-paired stem, it is likely that the mutation would interfere with the formation of the terminator structure and allow RNA polymerase to transcribe the downstream bgl gene cluster, thereby leading to overexpression of the bglF gene. Fig. 2 The bglF134 up mutation identified in the suppressor strain SPH1. The bglF134 up mutation, a G-to-T exchange at 134 bp upstream of the bglF gene, is located just near the putative ribonucleic antiterminator (RAT) sequence to which the bglG-encoded antiterminator protein binds in response to the presence of β-glucoside (Kotrba et al. 2003; Tanaka et al. 2009 ). The putative RAT sequence and transcriptional terminator sequence are indicated by the gray line and stem loop, respectively. The −10 and −35 regions of the potential promoter of bglF are boxed. The corresponding genomic regions in C. glutamicum ATCC 13032 and C. glutamicum R are also shown. The former strain ATCC 13032 lacks the β-glucoside utilization system consisting of the bglF-bglA-bglG gene cluster, while the latter strain R has two functional sets of the gene cluster at different positions in its genome (Tanaka et al. 2009) 
Effects of bglF modifications on growth
To substantiate the glucose-uptake capability of the bglF gene product, we examined the effect of its expression on growth on glucose in strain WTΔptsH. For this purpose, the coding region of bglF was cloned on a multi-copy vector so as to be constitutively expressed under the promoter of the endogenous gapA gene encoding glyceraldehyde 3-phosphate dehydrogenase. We then introduced the resulting plasmid pCbglF into strain WTΔptsH. As shown in Fig. 5a , the plasmid could confer the ability to grow in MM medium with glucose as the sole carbon source on the PTS-negative strain, proving that the bglF gene product plays a role in glucose uptake. When a ptsI-disrupted strain, WTΔptsI, and a double-disrupted strain of both ptsH and ptsI, WTΔptsHI, were used as PTS-negative hosts instead of strain WTΔptsH, similar recoveries of growth on glucose were observed (Fig. 5b, c) . On the other hand, inframe deletion of the bglF inner sequence in strain SPH1 thoroughly abolished growth on glucose (Fig. 5a) , which reinforced our conclusion.
Involvement of glucokinase in growth of strain SPH1
Considering the results mentioned above, strain SPH1 was assumed to take up glucose by the bglF-specified permease and then phosphorylate by any of the three known native glucokinases, namely, GLK, PPGK, and CGL2647, encoded by glk, ppgK, and Cgl2647, respectively. If so, simultaneous defects of all three glucokinases must result in defective growth on glucose. To verify this, we disrupted all three genes through in-frame deletion of the corresponding inner sequences in strain SPH1. The resulting triple-knockout mutant, designated SPHΔggg, actually showed no growth on glucose (Fig. 6) . Plasmid-mediated expression of any of the three genes under the gapA promoter in strain SPHΔggg restored the growth of the mutant on glucose (Fig. 6) , proving that strain SPH1 undoubtedly depends on glucokinase(s) for its growth on glucose (Fig. 7) .
Discussion
In our previous report (Ikeda et al. 2011) , we showed that the myo-inositol transporters IolT1 and IolT2 function as alternatives to the glucose-PTS in C. glutamicum. In this study, we identified a third glucose uptake bypass as the bglF-specified EII component of the β-glucoside-PTS in C. glutamicum ATCC 31833. The bglF gene product EII Bgl is known to be a member of the PtsG family of EII proteins (Schnetz et al. 1990) , and it shows significant sequence identity (29.9 %) with PtsG, a glucose-specific EII Glc component, while it shares only 17.1 and 15.2 % with IolT1 and IolT2, respectively. The presence of a β-glucoside-PTS in C. glutamicum was first described in another wild-type C. glutamicum R strain (Kotrba et al. 2003) , and the PTS is known to mediate the uptake of β-glucosides such as salicin and arbutin. Actually, the wild-type strain WT-96 used in this study showed growth in MM medium with the β-glucoside arbutin as the sole carbon source, whereas disruption of bglF or ptsH in the wild-type strain thoroughly abolished growth on arbutin (data not shown), confirming that bglF functions as the β-glucoside-PTS, as it does in C. glutamicum R. It is already known (Kotrba et al. 2003; Tanaka et al. 2009 ) that the β-glucoside utilization system consisting of the bglF-bglAbglG gene set is missing from the representative wild-type strain C. glutamicum ATCC 13032. This finding is worth noting because the ATCC 13032 genomic information has generally been used to design C. glutamicum DNA microarrays. So did our microarrays. This seems to be a reason why our first attempt to identify the bypass gene using the microarrays resulted in failure.
The β-glucoside-PTS is known to mediate the uptake not only of the β-glucosides but also of glucose in E. coli, Bacillus subtilis, and C. glutamicum (Schnetz et al. 1990; Schilling et al. 2006; Tanaka et al. 2011) . Nevertheless, our study has shown that the EII component alone can mediate glucose uptake enough to allow normal cell growth on glucose. This conclusion is based on our observations that plasmidmediated expression of the bglF gene in the PTS-negative strains with deletions of ptsH, ptsI, and both allowed any of the mutants to grow in MM medium with glucose as the sole carbon source (Fig. 5) . These results indicate that the bglFspecified EII component of the β-glucoside-PTS plays a role in glucose uptake independently from the other two general components EI and HPr, encoded by ptsI and ptsH, respectively. This finding is noteworthy because carbohydrate transport by the bacterial PTS occurs by tightly coupling carbohydrate translocation and phosphorylation, and it is believed that EII alone is unable to catalyze carbohydrate transport in the absence of either or both of the two phosphoryl-transferring components EI and HPr (Postma and Stock 1980) . To the best of our knowledge, there seems no previous report demonstrating that a wild-type EII component alone functions as a sugar permease at a level allowing normal cell growth. If there is any, the transport potency would be insufficient for cell growth, as in the case of, e.g., the treB-specified EII component of the trehalose-PTS in an E. coli W strain (Steen et al. 2014) . 
Although bacterial EII
Glc components require the general PTS components EI and HPr to catalyze glucose transport, some specific mutations that lead to the uncoupling of glucose transport from phosphorylation have been isolated in the EII Glc of enteric bacteria (Postma 1981; Ruijter et al. 1992 ). Contrary to the wild-type protein, the uncoupled EII Glc derivatives are able to transport glucose in the absence of EI and HPr. In these cases, it has been suggested that the mutant EII Glc allows translocation of glucose across the membrane via a mechanism of facilitated diffusion (Ruijter et al. 1990 (Ruijter et al. , 1992 . Although the mechanism of glucose uptake in our newly discovered glucose uptake bypass remains to be clarified, it seems possible that the wild-type EII Bgl of C. glutamicum functions via a similar mechanism of facilitated diffusion even under a PTS-negative background. This implies that there would be no energetic demands for glucose transport via the C. glutamicum EII Bgl protein alone, as has been suggested for glucose transport via the uncoupled EII Glc derivatives of enteric bacteria (Ruijter et al. 1991) . In relation to this, a specific mutation that leads to the uncoupling of glucose transport from phosphorylation has been reported for E. coli EII Bgl (Schnetz et al. 1990 ). The third glucose uptake bypass identified in this study, like the previously identified bypasses IolT1 and IolT2, is a non-PTS route in which growth on glucose depends on endogenous glucokinase(s) (Fig. 7) . This was not only genetically proved in this study but is also supported by our previous observation that strain SPH1 shows clear resistance to 2-deoxyglucose, a glucose analog that is known to be a toxic substrate for the glucose-PTS of C. glutamicum (Mori and Shiio 1987) . The same phenotype has been observed in the other bypass strain SPH2, but not in the wild-type strain expressing the native PTS (Ikeda et al. 2011 ). These results indicate that strain SPH1, like strain SPH2, takes up and phosphorylates glucose via a 2-deoxyglucose-resistant non-PTS system, undoubtedly involving the endogenous permease and glucokinase(s). Although the PTS uses phosphoenolpyruvate (PEP) to phosphorylate glucose, the non-PTS routes do not; they therefore have the practical advantage of increased availability of PEP for other biosynthetic reactions, e.g., for amino acid biosynthesis, as has been demonstrated in aromatic production by E. coli (Flores et al. 1996) . Although data are not shown, we have confirmed that significant yield improvement can be obtained when a defined lysine-producing strain of C. glutamicum expresses the non-PTS route(s) instead of the original PTS (Ikeda 2012; Ikeda et al. 2011 ). This positive effect has also been explained by increased availability of PEP, which contributes to increased supply of carbon from central metabolism into the lysine-biosynthetic pathway through the anaplerotic reaction involving PEP carboxylase. Based on these original results, we have applied for an international patent, and currently hold a patented technology in the USA (Ikeda et al. 2013b) . Considering the known characteristics of the C. glutamicum PTS, e.g., its relative sensitivity to increased osmolality (Gourdon et al. 2003) , the potential practical advantage of the non-PTS routes seems to go beyond simply saving PEP for other biosynthetic reactions. Switching the glucose transport system from the original PTS to a non-PTS route(s), or co-expressing the PTS and the non-PTS route(s), could impact the industrial fermentation processes c l G c l G Fig. 7 The glucose-PTS and potential glucose uptake bypasses in C. glutamicum ATCC 31833. As exemplified by strain SPH2, inactivation of the putative transcriptional regulator IolR under a PTSnegative background leads to a strain expressing the iolT1-specified glucose uptake bypass (IolT1) instead of the native PTS (Ikeda et al. 2011) . On the other hand, introduction of the bglF134 up mutation into a PTS-negative background results in a strain expressing the bglF-specified glucose uptake bypass (EII Bgl ) instead of the native PTS, as exemplified by strain SPH1. In these PTS-independent glucose uptake bypasses, the ATP-or polyphosphate (PolyPn)-dependent phosphorylation of intracellular glucose depends on any of the three known native glucokinases GLK, PPGK, and CGL2647, encoded by glk, ppgK, and Cgl2647, respectively that use C. glutamicum. The discovery of the third non-PTS route for glucose uptake in this study will surely expand the options for the development of more efficient production strains in this industrially important microorganism.
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